Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary

Explore clinical trials studying Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary trial results

Recruiting

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

NCT06636734

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Carcinoma (1)
Carcinoma, Squamous Cell (1)
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)
Head and Neck Neoplasms (1)
Hypopharyngeal Neoplasms (1)
Laryngeal Diseases (1)
Laryngeal Neoplasms (1)
Metastatic Head and Neck Squamous Cell Carcinoma (1)

Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary

Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary trial results

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Related conditions